APT Pharmaceuticals, Inc. Report issue

For profit Phase 3
Founded: Burlingame CA United States (2005)
Status: Defunct (2008)

Organization Overview

First Clinical Trial
2008
NCT00633373
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

cyclosporine (sandimmune) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchiolitis (Phase 3)

Bronchiolitis Obliterans (Phase 3)

Respiratory Aspiration (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1